Cargando…

Impact of Plastic-Related Compounds on P-Glycoprotein and Breast Cancer Resistance Protein In Vitro

Plastic in oceans degrades to microplastics and nanoplastics, causing various problems for marine fauna and flora. Recently, microplastic has been detected in blood, breast milk and placenta, underlining their ability to enter the human body with still unknown effects. In addition, plastic contains...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosellini, Matteo, Turunen, Petri, Efferth, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058098/ https://www.ncbi.nlm.nih.gov/pubmed/36985682 http://dx.doi.org/10.3390/molecules28062710

Ejemplares similares

The Effect of Plastic-Related Compounds on Transcriptome-Wide Gene Expression on CYP2C19-Overexpressing HepG2 Cells
por: Rosellini, Matteo, et al.
Publicado: (2023)

P-glycoprotein expression in treated and untreated human breast cancer.
por: Schneider, J., et al.
Publicado: (1989)

In Silico and In Vitro Identification of P-Glycoprotein Inhibitors from a Library of 375 Phytochemicals
por: Schäfer, Julia, et al.
Publicado: (2023)

Inhibition of P-glycoprotein by two artemisinin derivatives
por: Steglich, Babette, et al.
Publicado: (2012)

Screening of Natural Compounds as P-Glycoprotein Inhibitors against Multidrug Resistance
por: Marques, Sérgio M., et al.
Publicado: (2021)

Interactions of retinoids with the ABC transporters P-glycoprotein and Breast Cancer Resistance Protein
por: Tarapcsák, Szabolcs, et al.
Publicado: (2017)

A Machine Learning-Based Prediction Platform for P-Glycoprotein Modulators and Its Validation by Molecular Docking
por: Kadioglu, Onat, et al.
Publicado: (2019)

Expression of P-glycoprotein and breast cancer resistance protein in three cases of canine lymphoma showing drug resistance
por: HYOKAI, Sachiko, et al.
Publicado: (2021)

Docking Applied to the Prediction of the Affinity of Compounds to P-Glycoprotein
por: Palestro, Pablo H., et al.
Publicado: (2014)

Binding Site Interactions of Modulators of Breast Cancer Resistance Protein, Multidrug Resistance-Associated Protein 2, and P-Glycoprotein Activity
por: Deng, Feng, et al.
Publicado: (2020)

HZ08 Reverse P-Glycoprotein Mediated Multidrug Resistance In Vitro and In Vivo
por: Hu, Zheyi, et al.
Publicado: (2015)

The effects of ultrasound exposure on P-glycoprotein-mediated multidrug resistance in vitro and in vivo
por: Huang, Chixiong, et al.
Publicado: (2018)

CPT-11 sensitivity in relation to the expression of P170-glycoprotein and multidrug resistance-associated protein.
por: Jansen, W. J., et al.
Publicado: (1998)

Biochemical interaction of anti-HCV telaprevir with the ABC transporters P-glycoprotein and breast cancer resistance protein
por: Fujita, Yuria, et al.
Publicado: (2013)

Expression and Cellular Distribution of P-Glycoprotein and Breast Cancer Resistance Protein in Amyotrophic Lateral Sclerosis Patients
por: van Vliet, Erwin A, et al.
Publicado: (2020)

Effect of GenX on P-Glycoprotein, Breast Cancer Resistance Protein, and Multidrug Resistance–Associated Protein 2 at the Blood–Brain Barrier
por: Cannon, Ronald E., et al.
Publicado: (2020)

Overcoming multidrug-resistance in vitro and in vivo using the novel P-glycoprotein inhibitor 1416
por: Xu, Yan, et al.
Publicado: (2012)

Overexpression of lung resistance-related protein and P-glycoprotein and response to induction chemotherapy in acute myelogenous leukemia
por: Tsuji, Kazue, et al.
Publicado: (2012)

Abundance of P-glycoprotein and Breast Cancer Resistance Protein Measured by Targeted Proteomics in Human Epileptogenic Brain Tissue
por: Brukner, Aniv Mann, et al.
Publicado: (2021)

Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein.
por: Quesada, A. R., et al.
Publicado: (1996)

Compound 968 reverses adriamycin resistance in breast cancer MCF-7(ADR) cells via inhibiting P-glycoprotein function independently of glutaminase
por: Yang, Ronghui, et al.
Publicado: (2021)

ERBB and P‐glycoprotein inhibitors break resistance in relapsed neuroblastoma models through P‐glycoprotein
por: Rösch, Lisa, et al.
Publicado: (2022)

The expression and significance of P-glycoprotein, lung resistance protein and multidrug resistance-associated protein in gastric cancer
por: Hu, Wen-Qing, et al.
Publicado: (2009)

An in vitro evaluation of guanfacine as a substrate for P-glycoprotein
por: Gillis, Nancy K, et al.
Publicado: (2011)

Classification of P-glycoprotein-interacting compounds using machine learning methods
por: Prachayasittikul, Veda, et al.
Publicado: (2015)

Multiclass Classifier for P-Glycoprotein Substrates, Inhibitors, and Non-Active Compounds
por: Mora Lagares, Liadys, et al.
Publicado: (2019)

Optimization of dose and route of administration of the P‐glycoprotein inhibitor, valspodar (PSC‐833) and the P‐glycoprotein and breast cancer resistance protein dual‐inhibitor, elacridar (GF120918) as dual infusion in rats
por: Rowbottom, Christopher, et al.
Publicado: (2021)

Enhanced Brain Disposition and Effects of Δ(9)-Tetrahydrocannabinol in P-Glycoprotein and Breast Cancer Resistance Protein Knockout Mice
por: Spiro, Adena S., et al.
Publicado: (2012)

Olomoucine II, but Not Purvalanol A, Is Transported by Breast Cancer Resistance Protein (ABCG2) and P-Glycoprotein (ABCB1)
por: Hofman, Jakub, et al.
Publicado: (2013)

High Intrinsic Expression of P-glycoprotein and Breast Cancer Resistance Protein in Canine Mammary Carcinomas Regardless of Immunophenotype and Outcome
por: Levi, Michela, et al.
Publicado: (2021)

P‐Glycoprotein and Breast Cancer Resistance Protein Transporter Inhibition by Cyclosporine and Quinidine on the Pharmacokinetics of Oral Rimegepant in Healthy Subjects
por: Bhardwaj, Rajinder, et al.
Publicado: (2022)

COVID-19 drugs: potential interaction with ATP-binding cassette transporters P-glycoprotein and breast cancer resistance protein
por: Lee, Jaeok, et al.
Publicado: (2022)

Dissimilar Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Distribution of Erlotinib to the Retina and Brain in Humans and Mice
por: Biali, Myriam El, et al.
Publicado: (2023)

Geniposide reverses multidrug resistance in vitro and in vivo by inhibiting the efflux function and expression of P-glycoprotein
por: Huang, Hefei, et al.
Publicado: (2017)

Proteins regulating the intercellular transfer and function of P-glycoprotein in multidrug-resistant cancer
por: Pokharel, Deep, et al.
Publicado: (2017)

Interaction of tamoxifen with the multidrug resistance P-glycoprotein.
por: Callaghan, R., et al.
Publicado: (1995)

P glycoprotein (P-gp) and drug resistance--time for reappraisal?
por: Kaye, S. B.
Publicado: (1993)

Chemical biology fluorescent tools for in vitro investigation of the multidrug resistant P-glycoprotein (P-gp) expression in tumor cells
por: Daumar, Pierre, et al.
Publicado: (2023)

Design, Synthesis and Biological Evaluation of Quinazolinamine Derivatives as Breast Cancer Resistance Protein and P-Glycoprotein Inhibitors with Improved Metabolic Stability
por: Cai, Chao-Yun, et al.
Publicado: (2023)

The Effects of Cetirizine on P-glycoprotein Expression and Function In vitro and In situ
por: Mesgari Abbasi, Mehran, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1i7nae6r5u37mf80ekm1e2hmq9